×

Pre Market Report, June 4, 2018

June 4, 2018
Time: 8.45 am

Pre Market Report:


  1. Asian markets are higher.
  2. SGX Nifty is higher by about 50 points.
  3. HDFC Bank will be in focus today.
  4. FIIs are allowed to buy 4.3 crore shares today.
  5. That may translate into Rs 8000 crore worth of buying in HDFC Bank.
  6. People say it is likely to go higher by 5% by the end of the day.
  7. In that case, Bank Nifty and Nifty also will go up.
  8. Monsoon progress has been good.
  9. Auto sales numbers were good.
  10. In fact Auto index was the only index that ended in Green on Friday.
  11. Later in the week RBI policy will also be in the focus.
  12. FII selling is not that aggressive.
  13. DIIs continue to buy.
  14. Markets may be in consolidation mode until RBI policy on June 6.
  15. Nifty 10200PE has the highest open interest among Puts.
  16. Last Friday I sold lot of puts at Rs 30.
  17. Waiting for HDFC Bank FII buying to be fully factored in before selling any Calls.
  18. I may sell 10000PE today if there is any intraday dip towards 10680.
  19. Bank Nifty 25000PE can be sold with some hedging.
  20. Dare devils can consider selling 27000 straddle.
  21. Nifty future may trade between 10680 and 10800.



Comments

  1. great sir keep up good work

    ReplyDelete
  2. 5% is lot of slippage for FII's, how long is this window? They have to bring the markets down before / during the HDFC buy, won't they? Very interesting. And CRUDE is slipping as well. So, all in all we can expect a small rally in NIFTY by EOD?

    Your analysis is absolutely great. God bless you for sharing your thoughts.

    ReplyDelete
  3. Today only i start watch Ur bloga sir..

    ReplyDelete
  4. any puts selling has to be done with care as there is sign of weakness today and nifty can fall. This is as per my OI and price analysis. I will attempt long only if 10716 gets support.

    ReplyDelete
  5. This week BNF may expire above 26900.... caution while writing CE....

    ReplyDelete
  6. Was the FII open market buy window on June 1st and not June 4th ?

    ReplyDelete
  7. As per the USFDA website, Aurobindo Pharma has received final USFDA approval for Atazanavir Sulfatefinancial advisory company

    ReplyDelete

Post a Comment